Integra LifeSciences Holdings Corporation (IART) vs Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
A side-by-side comparison of Integra LifeSciences Holdings Corporation and Lumexa Imaging Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IART
Integra LifeSciences Holdings Corporation
$13.25HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$10.59HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — IART vs LMRI
growth of $100 · dividends reinvested · last 1yIART -1.5% (-1.5%/yr)LMRI -41.8% (-41.8%/yr)IART compounded faster over this window
IART LMRI
IART vs LMRI: by the numbers
- •IART is the larger company ($1.03B vs $1.02B market cap).
- •Both run net losses; IART's is the smaller (-0.44% vs -2.66% net margin).
Metrics side by side
Valuation
| Metric | IART | LMRI |
|---|---|---|
| Forward P/E | 5.43 | 16.49 |
| P/S ratio | 0.63 | 0.97 |
| P/B ratio | 0.98 | 1.65 |
| EV / EBITDA | 3.53 | 27.89 |
| FCF yield | N/A | 3.13% |
Profitability
| Metric | IART | LMRI |
|---|---|---|
| Gross margin | 53.74% | 11.80% |
| Operating margin | 4.18% | 1.38% |
| Net margin | -0.44% | -2.66% |
| ROE | -0.69% | -4.51% |
| ROIC | 20.01% | 0.86% |
Growth (annualized)
| Metric | IART | LMRI |
|---|---|---|
| Revenue CAGR (5Y) | 1.77% | N/A |
| Total return CAGR (5Y) | -28.16% | N/A |
Go deeper
Dig into the metrics
Integra LifeSciences ROELumexa Imaging Holdings, Inc. Common Stock ROEIntegra LifeSciences operating marginLumexa Imaging Holdings, Inc. Common Stock operating marginIntegra LifeSciences revenue growthLumexa Imaging Holdings, Inc. Common Stock revenue growthIntegra LifeSciences free cash flowLumexa Imaging Holdings, Inc. Common Stock free cash flow
Integra LifeSciences & Lumexa Imaging Holdings, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.